No, any changes to your dosing schedule should be made in consultation with a licensed healthcare provider
Women who are already navigating the hormonal transition of menopause while using semaglutide face a compound challenge that requires careful monitoring
For association analyses, Pearson correlation was used to test quantitative variables, and Spearman correlation was used for nonquantitative variables
Orlistat is currently the only FDA-approved lipase inhibitor for weight loss
The plaintiff used Ozempic from November 2023 to June 2024 and is now pursuing claims for failure to warn, negligence, breach of warranty, fraudulent concealment, and design defect
Weight loss may vary depending on individual factors like metabolism, activity levels, and adherence to the plan